BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34096581)

  • 21. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
    Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
    Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
    Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma.
    Prego MT; Dias MJ; Ferreira RL; Gonçalves S; Dias Domingues T; Junius G; Van den Steen E; Galac S; Leal RO
    J Vet Intern Med; 2023; 37(3):910-914. PubMed ID: 37057306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
    Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma.
    Taylor RL; Singh RJ
    Clin Chem; 2002 Mar; 48(3):533-9. PubMed ID: 11861444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
    Remde H; Pamporaki C; Quinkler M; Nölting S; Prejbisz A; Timmers HJLM; Masjkur J; Fuss CT; Fassnacht M; Eisenhofer G; Deutschbein T
    Hypertension; 2022 Jun; 79(6):1257-1264. PubMed ID: 35378989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
    Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of liquid chromatography-tandem mass spectrometry method for quantification of plasma metanephrines for differential diagnosis of adrenal incidentaloma.
    Lee SM; Lee MN; Oh HJ; Cho YY; Kim JH; Woo HI; Park HD; Lee SY
    Ann Lab Med; 2015 Sep; 35(5):519-22. PubMed ID: 26206689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary free metanephrines measurement in dogs with adrenal gland diseases using a new simple liquid chromatography tandem mass spectrometry method.
    Sasaki N; Ikenaka Y; Inoue Y; Ichise T; Nagata N; Ishizuka M; Nakayama SM; Nakamura K; Takiguchi M
    J Vet Med Sci; 2021 Apr; 83(4):648-655. PubMed ID: 33678734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
    Unger N; Hinrichs J; Deutschbein T; Schmidt H; Walz MK; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):494-500. PubMed ID: 22696168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea.
    King TFJ; Mok Y; Dacay LM; Wong HS; Hsu PP; Tan A; Wong KM; Saffari SE; Lenders JWM; Puar TH
    J Clin Endocrinol Metab; 2024 Feb; 109(3):844-851. PubMed ID: 37721483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma.
    Pommer G; Pamporaki C; Peitzsch M; Remde H; Deutschbein T; Nölting S; Müller LM; Braun L; Gruber S; Pecori A; Hampson S; Davies E; Stell A; Rossi GP; Lenzini L; Ceccato F; Timmers HJLM; Deinum J; Amar L; Blanchard A; Baron S; Fassnacht M; Dobrowolski P; Januszewicz A; Zennaro MC; Prejbisz A; Eisenhofer G
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3689-e3698. PubMed ID: 35767279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.
    Xiong X; Zhang Y
    Anal Bioanal Chem; 2020 May; 412(12):2763-2775. PubMed ID: 32130439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs.
    Cho YY; Song KH; Kim YN; Ahn SH; Kim H; Park S; Suh S; Kim BJ; Lee SY; Chun S; Koh JM; Lee SH; Kim JH
    Endocrine; 2016 Oct; 54(1):206-216. PubMed ID: 27481364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.
    Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ
    J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.